EPLR 2/2018 (Vol. 2)

Editorial

Sabrina Röttger-Wirtz

Page 61 - 62

Beyond Protecting Economic Interests – SPCs as a Tool to Support Public Health Goals

Florian Schmidt

Page 63 - 71

Rewarding Innovation: Pharmaceutical Incentives as a Crucial Instrument to Foster Public Health

Laëtitia Bénard, Jacqueline Bore, Eveline Van Keymeulen

Page 72 - 84

Denmark ∙ The Danish Medicines Council: A New Prioritisation Organ for Medicine Use in Hospitals

Michael Christiani Havemann, Lise Aagaard

Page 85 - 89

The Netherlands ∙ Proposed Solutions to Tackle Expensive Medicines in The Netherlands: A Critical Review

Hanneke MJ Later-Nijland

Page 90 - 99

An Eye for an Eye? Off-label Use and Misleading Information: Hoffmann-La Roche v AGCM

Tamara Klimenta, Wolf Sauter

Page 100 - 107

The EMA Access to Documents Policy Put to Trial

Sabrina Röttger-Wirtz

Page 108 - 115

Jurisdiction

Page 116 - 117

New EU Pharmaceutical Law and Policy

Page 118